Our findings revealed that upregulation of DDX11-AS1 in HCC has an association with aggressive progression with poor prognosis and that DDX11-AS1 may function as a prognostic and diagnostic marker for HCC. This evidence concerns the gene DDX11 and hepatocellular carcinoma.